GRCE
Grace Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GRCE fundamentals
Grace Therapeutics (GRCE) released its earnings on Aug 12, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.21 (YoY 0.00%), beat estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.21
0.00%
Report date
Aug 12, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Grace Therapeutics (GRCE) key financial stats and ratios, covering profitability, financial health, and leverage.
Grace Therapeutics (GRCE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Grace Therapeutics (GRCE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Grace Therapeutics (GRCE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Grace Therapeutics (GRCE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Grace Therapeutics (GRCE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Grace Therapeutics’s earnings call?Did Grace Therapeutics beat or miss consensus estimates last quarter?What guidance did Grace Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Grace Therapeutics next quarter?What does Grace Therapeutics do and what are its main business segments?What factors drove the changes in Grace Therapeutics's revenue and profit?What is Grace Therapeutics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Grace Therapeutics year over year?
